Stroke, a leading cause of serious, long-term disability in the United States, ranks as the fifth leading cause of death in South Carolina.
In an effort to decrease the risk of stroke for patients who might not be a candidate for other stroke treatments, McLeod offers a new minimally invasive procedure to treat carotid artery disease.
...
Carotid endarterectomy is a procedure performed by a vascular surgeon to treat carotid artery disease. During this procedure, the vascular surgeon exposes the carotid artery through an incision on the side of the neck. The artery, after being clamped on both sides of the blockage, is then opened to access the plaque. The plaque is removed from inside the artery and the artery then sewn back together.
This is an effective treatment for decreasing the risk of stroke. However, some patients have medical conditions that place them at high risk for carotid endarterectomy.
For these patients, a new procedure called transcarotid arterial revascularization (TCAR) is now available. During the procedure, the surgeon makes a very small, one-inch incision just above the collarbone to gain access to the blocked artery while the patient is under local anesthesia. TCAR is a more viable option for patients who have medical conditions that would prohibit them from undergoing an open procedure like the carotid endarterectomy.
Read More: http://www.scnow.com/living/health/article_b174abf0-f496-11e7-ae78-f7dfd6771828.html
Via: SCNow Via: OncoMed Year-end 2017 Cash Balance of $103.1 Million OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings has Resigned1/4/2018
Via: OncoMed Board of Directors has initiated search to identify successor Via: TechCrunch Leslie Trigg Via: PR Newswire Minimally Invasive Technology Temporarily Reverses Blood Flow in the Brain to Prevent Devastating Strokes Sacred Heart Hospital in Pensacola is the first hospital in Northwest Florida and Alabama to offer an innovative new treatment for patients at risk for stroke due to blockages in the carotid arteries of the neck. Via: NewCo Shift Smart, young, talented, and very much not bro-tastic. Gatekeepers, Sheriffs, and Champions: The Role of HR Benefits Managers in the Era of Digital Health11/30/2017
Via: Omada Health In September, Rob Coppedge of Echo Ventures made waves with a CNBC-published commentary “Digital Health is Dead.” The content of his piece, however, delivered more nuance than its headline. Rob’s issue was not with the rise of an industry that has brought unprecedented consumer focus and innovation to a stagnated healthcare system; his critique was instead focused on the buzzword-focused ecosystem that has grown up around it. The final section of his piece is titled “Digital Health is Dead - Now the Work Begins.” Via: Endovascular Today November 29, 2017—Silk Road Medical, Inc. announced data from the ROADSTER 1 and 2 trials demonstrating the safety and efficacy of the company’s Enroute transcarotid neuroprotection and Enroute transcarotid stent system, which are specifically designed and indicated for transcarotid artery revascularization (TCAR). The data were first presented at the 2017 VEITHsymposium, held November 14–18 in New York, New York. Via: OncoMed Office of the President continues to perform the duties of President and CEO |
Archives
October 2023
|